Follow
Stephen Ackland
Stephen Ackland
Medical Oncology, Calvary Mater Hospital: University of Newcastle
Verified email at newcastle.edu.au - Homepage
Title
Cited by
Cited by
Year
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
LB Saltz, JV Cox, C Blanke, LS Rosen, L Fehrenbacher, MJ Moore, ...
New England Journal of Medicine 343 (13), 905-914, 2000
39192000
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line …
MER O’Brien, N Wigler, M Inbar, R Rosso, E Grischke, A Santoro, ...
Annals of oncology 15 (3), 440-449, 2004
18862004
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
11102005
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation …
SY Ngan, B Burmeister, RJ Fisher, M Solomon, D Goldstein, D Joseph, ...
J Clin Oncol 30 (31), 3827-33, 2012
9922012
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III …
NC Tebbutt, K Wilson, VJ Gebski, MM Cummins, D Zannino, ...
5052010
Basis for effective combination cancer chemotherapy with antimetabolites
GJ Peters, CL Van der Wilt, CJA Van Moorsel, JR Kroep, AM Bergman, ...
Pharmacology & therapeutics 87 (2-3), 227-253, 2000
3902000
High-dose methotrexate: a critical reappraisal.
SP Ackland, RL Schilsky
Journal of Clinical Oncology 5 (12), 2017-2031, 1987
3261987
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer
JF Bishop, J Dewar, GC Toner, J Smith, MHN Tattersall, IN Olver, ...
Journal of Clinical Oncology 17 (8), 2355-2355, 1999
2631999
Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
DC Talbot, V Moiseyenko, S Van Belle, SM O'reilly, E Alba Conejo, ...
British journal of cancer 86 (9), 1367-1372, 2002
2502002
Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer
C Odelli, D Burgess, L Bateman, A Hughes, S Ackland, J Gillies, ...
Clinical oncology 17 (8), 639-645, 2005
2232005
Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer
SJ Clarke, R Abratt, L Goedhals, MJ Boyer, MJ Millward, SP Ackland
Annals of oncology 13 (5), 737-741, 2002
2082002
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
MR Stockler, VJ Harvey, PA Francis, MJ Byrne, SP Ackland, B Fitzharris, ...
Journal of clinical oncology 29 (34), 4498-4504, 2011
1822011
Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer
A Sobrero, S Ackland, S Clarke, R Perez-Carrión, S Chiara, J Gapski, ...
Oncology 77 (2), 113-119, 2008
1672008
Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer
JAM Van Laar, YM Rustum, SP Ackland, CJ Van Groeningen, GJ Peters
European Journal of Cancer 34 (3), 296-306, 1998
1521998
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines
A McCluskey, SP Ackland, MC Bowyer, ML Baldwin, J Garner, ...
Bioorganic chemistry 31 (1), 68-79, 2003
1482003
Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial
International Breast Cancer Study Group (IBCSG)
Journal of the National Cancer Institute 94 (14), 1054-1065, 2002
1482002
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international …
TJ Price, D Zannino, K Wilson, RJ Simes, J Cassidy, GA Van Hazel, ...
Annals of oncology 23 (6), 1531-1536, 2012
1422012
The physical and psycho‐social experiences of patients attending an outpatient medical oncology department: a cross‐sectional study
Newell, Girgis, Ackland
European journal of cancer care 8 (2), 73-82, 1999
1391999
Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.
HP Gurney, S Ackland, V Gebski, G Farrell
Journal of clinical oncology 16 (7), 2299-2304, 1998
1371998
Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma …
N Ansari, MJ Solomon, RJ Fisher, J Mackay, B Burmeister, S Ackland, ...
Annals of surgery 265 (5), 882-888, 2017
1262017
The system can't perform the operation now. Try again later.
Articles 1–20